SABI Mind

11/20/2023

You’re invited to experience the SABI Mind philosophy and meet the team of talented experts from the Calgary clinic.

Get a first-hand look at the Calgary Healing Centre and have the opportunity to learn more about psychedelic-assisted therapies from the team of mental health and chronic pain specialists.

Feel free to stop in at the clinic with a guest. Light refreshments and snacks will be served.

When: November 23, 3:00pm - 6:00pm MST

Where: SABI Mind Calgary Clinic: Suite 202, 1615 10 Ave SW.

RSVP at the link in bio

11/13/2023

SABI Mind presents Full Circle on November 30th, 6:00 PM - 7:00 PM MST

An ongoing series that features insights and in-depth conversations with psychedelic-assisted therapy professionals.

Join Philippe Lucas as he reveals insights into worldwide psychedelic use with the findings from the Global Psychedelic Survey. This is the most extensive assessment of global psychedelic use to date and will help to shape the future of psychedelic research and policy.

This free 45-minute moderated presentation will take place virtually over Zoom, with a Q&A to follow.

Secure your free ticket at the link below.

In this session, President Philippe Lucas presents the findings of the Global Psychedelic Survey.

10/23/2023

Curious about Ketamine-Assisted Psychotherapy?

Want to know if you might benefit from our treatments?

Our team of physicians, therapists, and clinic staff is devoted to helping clients experience the beauty of mending in a safe therapeutic setting that optimizes the psychedelic experience. ⁠ ⁠

At SABI, you may safely explore your psyche, address the roots of suffering and trauma, and feel supported in integrating the resulting insights into your daily life in a structured way. ⁠

Book your consultation with our Experience Specialist and start your journey today.

link in our bio

https://www.sabimind.com/book-a-consultation

10/19/2023

Get your tickets for the upcoming MAPSCANADA webinar on Thursday, October 6th, 2023. This event will feature a panel of speakers, including SABI Mind President Philippe Lucas, PhD discussing Balancing Safety and Access: Cost Coverage for Psychedelic-Assisted Care.

Learn about the state of cost coverage for psychedelic-assisted care in Canada, the impact on patients paying out of pocket and more. Tickets are available at the link below.

Affordability greatly impacts patient access to psychedelic-assisted care. Join us in a conversation about options for cost-coverage.

10/16/2023

“Over 2.3 million Canadians who seek mental health treatments reported that their needs were unmet due to financial barriers, lack of awareness of services and social stigma.” - Mental health services in Canada: Barriers and cost-effective solutions to increase access.

At SABI Mind, we are committed to reducing barriers to access, increasing accessibility and breaking down the stigma associated with mental health challenges.

This is why we have created the Equitable Access Program (EAP). The EAP provides discounted chronic pain and mental health services for historically underserved, underrepresented and low-income patient populations.

For a list of eligible criteria, please visit us at the link below and find new hope in healing.

https://www.sabimind.com/eap

10/16/2023

“Over 2.3 million Canadians who seek mental health treatments reported that their needs were unmet due to financial barriers, lack of awareness of services and social stigma.” - Mental health services in Canada: Barriers and cost-effective solutions to increase access.

At SABI Mind, we are committed to reducing barriers to access, increasing accessibility and breaking down the stigma associated with mental health challenges.

This is why we have created the Equitable Access Program (EAP). The EAP provides discounted chronic pain and mental health services for historically underserved, underrepresented and low-income patient populations.

For a list of eligible criteria, please visit us at the link below and find new hope in healing.

/* Hide this on Mobile */ screen and (max-width:767px) { [data-section-id="633dbd50f4d72c4bea372385"] { display: none; } } /* Hide this on Tablet - Desktop */ screen and (min-width:768px) { [data-section-id="633dbd50f4d72c4bea372385"] { display: none; } }

10/11/2023

PsyCan recently released its 2023 white paper urging the Federal Government to look beyond the Special Access Program in regulating psychedelic substances.

PsyCan Vice-Chair, White Paper Committee Chair, and SABI Mind president Dr. Philippe Lucas Ph.D., said: “The Canadian healthcare system is based on the principle of patient and physician autonomy in making fundamental decisions about medical treatments. However, most psychedelic-assisted therapies are an exception to this – requiring individual federal government approval on a per-patient basis,”

You can follow the link below to read the full paper.

PsyCan — the not-for-profit trade association of legally-operating Canadian psychedelic companies — is pleased to share its 2023 White Paper on the future of psychedelic access in Canada: Beyond the Special Access Program — Regulatory Analysis and Recommendations on Psychedelic Access in Canad...

10/06/2023

SABI Mind presents Full Circle on October 25th 6:00 PM - 7:00 pm MST

An ongoing event series that features insights and in-depth conversations with psychedelic-assisted therapy professionals.

Explore how psychedelic neuroscience has helped to inform the emerging science of consciousness with Sidath Rankaduwa and discover a few philosophical issues that arise when we try to understand consciousness through the lens of psychedelics. Sidath will investigate questions such as: To what extent is the psychedelic state a "higher state" of consciousness? And what would it mean for a conscious state to be a "higher" state?

Sidath Rankaduwa is a Ph.D. student in Neuroscience at Western University, studying the effects of psychedelics -- particularly psilocybin -- on consciousness and cognition.

This free 45-minute moderated presentation will take place virtually over Zoom, with a Q&A to follow.

RSVP at the link below.

Sidath Rankaduwa will explore how psychedelic neuroscience has helped to inform the emerging science of consciousness.

10/02/2023

Join SABI Mind President Philippe Lucas PhD in Victoria at the Grow Up Conference and Expo – October 1-3, 2023.

Dr. Lucas will be moderating a panel on Navigating New Realms: Psychedelic Access, Safety, and Advocacy in Focus today Monday, October 2nd 2023 at 3:15 PM | Psychedelic Zone - Sidney Breakout Room.

”

For more details, visit:

The Annual Grow Up Conference, Awards and Expo is the largest Cannabis Growers Conference and Canada and is focused on the education, collaboration, networking and growth of the cannabis industry in Canada and North America. We bring Licensed Producers, Micro Growers, Growing Suppliers, Manufacturer...

09/20/2023

PsyPost’s recent online article featured the results of the Canadian Psychedelic Survey (CPS) and a new publication, “Changed Substance Use After Psychedelic Experiences Among Individuals in Canada,” from co-authors Philippe Lucas (SABI Mind), Kevin Boehnke and Dan Kruger from UMich.

Our gratitude to study sponsors MAPS PBC, SABI Mind and Psygen.

"In this large, online survey of Canadians using psychedelics naturalistically, nearly half of individuals reported substantial decreases in alcohol, to***co, and other substance use following psychedelic experiences, with 25.9% reporting decreased use for 5 weeks or more. Participants rated psilocybin as the most impactful psychedelic for ceasing or decreasing use of other substances and cited reductions in anxiety/depression and increased connectedness to self, others and nature as the most common explanatory factors for these changes”.

Read the full article at the link below.

An online survey published in the International Journal of Mental Health and Addiction found that after beginning psychedelic use, many adults reduced or stopped their intake of alcohol, antidepressants, and co***ne, but increased their consumption of cannabis and to***co. The study, based on self-r...

09/18/2023

Join SABI Mind President Philippe Lucas PhD along with Jules Evans Director of ‘The Challenging Psychedelic Experiences Project’ and David Mathai Johns Hopkins Psychedelic Centre Graduate for the first seminar from the Pscyhedelic Safety Group.

Psychedelic Safety Seminars seek to learn and share research on psychedelic harms and harm reduction.

This free event is for researchers, practitioners and interested members of the public.

This event will happen September 21st, 2023 on zoom from 5pm-6.30pm UK time / 12-1.30pm EST / 9am-10.30am PST. It's a free event.

Our three speakers will each speak for 15-20 minutes, with 30 minutes at the end for questions and discussions.

Sign up for free at the link below.

The first online Psychedelic Safety Seminar, seeking to learn and share research on psychedelic harms and harm reduction

07/23/2023

Do people need prior psychotherapy experience to engage effectively with psychedelic integration?⁠
⁠
“Not necessarily. It can be helpful if people have an existing framework for understanding their struggles; how they conceptualize the barriers to change. Prior experience can also provide tools like how to ground or how to cultivate a sense of safety when coping. But it’s not a mandatory prerequisite.” - Dr. Jessica McLachlan.⁠
⁠
Dr. Jessica McLachlan was one of our past Full Circle guests. In her talk, she covered the fundamentals of psychedelic integration. ⁠
⁠
Full Circle is an ongoing event series that features insights and in-depth conversations with psychedelic-assisted therapy professionals.⁠
⁠
Sign up for our newsletter at the link below for more information about upcoming Full Circle events.⁠

https://www.sabimind.com/landing-page

07/20/2023

Acute pain is often associated with an injury and is a temporary unpleasant sensation that resolves as a person heals. When pain persists for longer than three months, it is classified as chronic. Chronic pain is often invisible and affects not only a person's physical body but mental health.

People suffering from chronic pain face a range of challenges and often feel disbelieved and stigmatized.

At SABI, we believe that chronic pain and its associated challenges are not life sentences; they can be mended to achieve a new sense of wholeness. complete, comprehensive, full-circle care.

To learn more about our Ketamine Therapy for Chronic Pain (KTCP) program book a free consultation with our Client Experience Specialist at the link below.

https://www.sabimind.com/book-a-consultation

07/18/2023

Netherland-based interior design and architecture-focused magazine FRAME recently featured our Calgary Healing Centre and the work done by .

Solo Studio’s design fuses the Japanese philosophy of wabi-sabi (beauty in imperfection and impermanence) with residential cues like natural materials, diffused lighting and soft furniture to make visitors feel at home.

Read more at the link below.

https://www.sabimind.com/blog/wabi-sabi-meets-ketamine-why-this-canadian-clinic-is-counting-on-two-key-ingredients

07/09/2023

Our experience of pain is influenced by: biology, psychology, spiritual factors, and social factors. At SABI Mind, we understand and treat chronic pain with these factors in mind.

Our team of specialists offers an integrated, interdisciplinary, holistic approach to treating chronic pain conditions. Our chronic pain lead, Dr. Kelly Shinkaruk, is deeply committed to helping clients with chronic pain find relief and improve their quality of life through Ketamine Therapy for Chronic (KTCP).

If you or anyone you know suffers from chronic pain, consider booking a free consultation with our Experience Specialist at the link below.

https://www.sabimind.com/book-a-consultation

07/07/2023

Ketamine is now a validated "off-label" treatment for various chronic "treatment-resistant" mental illnesses, pain syndromes, and other conditions. “Off-label” means that ketamine does not have an indication for the treatment of depression, anxiety, or any other psychiatric condition.

However, a growing body of evidence suggests that the use of low-dose ketamine has been proven to provide ongoing beneficial effects in some individuals, including general mood improvement, reduction/resolution of suicidal ideation, improvements in behavioural patterns of sleep, appetite, and energy, and reductions in chronic pain.

Ketamine has also demonstrated benefits in individuals with anxiety conditions, including PTSD, and may yield gains to obsessive thinking or rumination patterns.

To learn more about ketamine and its healing applications, follow the link below.

https://www.sabimind.com/centres

07/05/2023

SABI Mind is recruiting participants in Canada's first clinical trial to investigate psychedelic-assisted psychotherapy in the treatment of individuals with Alcohol Use Disorder (AUD).

The study will utilize psilocybin, one of the chemicals found in several species of mushrooms, which, research has shown, has been safe and effective in treating several mental health conditions and substance abuse issues.

Recently, a study conducted by scientists at New York University found that participants with alcohol use disorder that received psilocybin-assisted therapy reduced heavy drinking by 83%, compared with a 51% reduction among those who received an antihistamine placebo.

If you or someone you know has been diagnosed with AUD and are interested in applying to participate in the study, you can do so at the link below.

https://www.sabimind.com/audstudy

06/22/2023

People facing discrimination and marginalization are often more likely to have chronic and more severe pain. ⁠
⁠
Chronic pain sufferers often face a range of challenges, including stigma. Since pain is largely subjective and an invisible condition, people suffering from chronic pain can experience feelings of isolation and encounter trouble with others, not believing their pain is real.⁠
⁠
At SABI Mind, we offer an integrated interdisciplinary, holistic approach to treating chronic pain conditions. Our pain specialist, Dr. Kelly Shinkaruk, is deeply committed to helping clients with chronic pain find relief and improve their quality of life through Ketamine Therapy for Chronic (KTCP). ⁠
⁠
Learn more about Chronic Pain at the link below.

https://www.sabimind.com/chronic-pain